Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lanying Du

Showing results (41-50 of 182) with videos related to

Pageof 19
Sort By:
Reviews in Medical Virology|September 19, 2012
Potential strategies and biosafety protocols used for dual-use research on highly pathogenic influenza virusesLanying Du, Ye Li, Jimin Gao, et al.
Emerging Microbes & Infections|June 4, 2015
Receptor-binding domains of spike proteins of emerging or re-emerging viruses as targets for development of antiviral vaccinesShibo Jiang, Lu Lu, Qi Liu, et al.
Cancer Letters|August 28, 2022
Corrigendum to "Nelfinavir, an HIV protease inhibitor, induces apoptosis and cell cycle arrest in human cervical cancer cells via the ROS-dependent mitochondrial pathway" [Cancer Letters 364 (2015) 79-88]Tong Xiang, Lanying Du, Petra Pham, et al.
Cancer Letters|May 5, 2015
Nelfinavir, an HIV protease inhibitor, induces apoptosis and cell cycle arrest in human cervical cancer cells via the ROS-dependent mitochondrial pathwayTong Xiang, Lanying Du, Petra Pham, et al.
International Journal of Molecular Sciences|May 27, 2026
Immunogenicity and Protection of mRNA Vaccine Encoding Spike Protein of SARS-CoV-2 Omicron-XEC SubvariantXiaoqing Guan, Hansam Cho, Qian Liu, et al.
Journal of Thoracic Disease|August 27, 2013
Receptor-binding domain as a target for developing SARS vaccinesXiaojie Zhu, Qi Liu, Lanying Du, et al.
International Journal of Molecular Sciences|September 14, 2024
Envelope Protein-Targeting Zika Virus Entry InhibitorsAbhijeet Roy, Qian Liu, Yang Yang, et al.
Nature Biomedical Engineering|December 9, 2020
Neutralizing antibodies for the treatment of COVID-19Shibo Jiang, Xiujuan Zhang, Yang Yang, et al.
Microbes and Infection|February 5, 2020
Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, ChinaFei Yu, Lanying Du, David M Ojcius, et al.
Expert Opinion on Therapeutic Targets|December 13, 2016
MERS-CoV spike protein: a key target for antiviralsLanying Du, Yang Yang, Yusen Zhou, et al.
Pageof 19

Showing results (41-50 of 182) with videos related to

Sort By:
Pageof 19
Reviews in Medical Virology|September 19, 2012
Potential strategies and biosafety protocols used for dual-use research on highly pathogenic influenza virusesLanying Du, Ye Li, Jimin Gao, et al.
Emerging Microbes & Infections|June 4, 2015
Receptor-binding domains of spike proteins of emerging or re-emerging viruses as targets for development of antiviral vaccinesShibo Jiang, Lu Lu, Qi Liu, et al.
Cancer Letters|August 28, 2022
Corrigendum to "Nelfinavir, an HIV protease inhibitor, induces apoptosis and cell cycle arrest in human cervical cancer cells via the ROS-dependent mitochondrial pathway" [Cancer Letters 364 (2015) 79-88]Tong Xiang, Lanying Du, Petra Pham, et al.
Cancer Letters|May 5, 2015
Nelfinavir, an HIV protease inhibitor, induces apoptosis and cell cycle arrest in human cervical cancer cells via the ROS-dependent mitochondrial pathwayTong Xiang, Lanying Du, Petra Pham, et al.
International Journal of Molecular Sciences|May 27, 2026
Immunogenicity and Protection of mRNA Vaccine Encoding Spike Protein of SARS-CoV-2 Omicron-XEC SubvariantXiaoqing Guan, Hansam Cho, Qian Liu, et al.
Journal of Thoracic Disease|August 27, 2013
Receptor-binding domain as a target for developing SARS vaccinesXiaojie Zhu, Qi Liu, Lanying Du, et al.
International Journal of Molecular Sciences|September 14, 2024
Envelope Protein-Targeting Zika Virus Entry InhibitorsAbhijeet Roy, Qian Liu, Yang Yang, et al.
Nature Biomedical Engineering|December 9, 2020
Neutralizing antibodies for the treatment of COVID-19Shibo Jiang, Xiujuan Zhang, Yang Yang, et al.
Microbes and Infection|February 5, 2020
Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, ChinaFei Yu, Lanying Du, David M Ojcius, et al.
Expert Opinion on Therapeutic Targets|December 13, 2016
MERS-CoV spike protein: a key target for antiviralsLanying Du, Yang Yang, Yusen Zhou, et al.
Pageof 19